Wegovy craze was all the rage on Q3 earnings calls
By Bhanvi Satija and Savyata Mishra Weight loss was the talk of this earnings season, making names such
2023-11-20 14:19
Retail investors crowd into Eli Lilly after weight-loss drug approval
By Bhanvi Satija and Amruta Khandekar Retail flows into Eli Lilly spiked to a more than two-year high
2023-11-17 21:25
Wegovy's heart benefits due to more than weight loss, Novo says
By Patrick Wingrove PHILADELPHIA (Reuters) -Novo Nordisk on Saturday said the heart protective benefits of its wildly popular Wegovy obesity
2023-11-12 22:57
Eli Lilly: still seeking UK approval on pen for weight-loss drug
By Maggie Fick and Ludwig Burger LONDON Eli Lilly on Thursday said it has not yet gained approval
2023-11-09 21:54
Weight loss drugs transforming healthcare, may help with addiction -Reuters Events
By Julie Steenhuysen and Caroline Stauffer CHICAGO A new class of weight loss drugs is transforming the U.S.
2023-11-09 19:29
Factbox-Corporate America weighs risks of the Ozempic effect
U.S. companies across sectors such as food and beverage makers and manufacturers of glucose monitors have faced investor
2023-10-20 10:55
Wegovy makes UK weight-loss debut even as Novo struggles with supplies
By Maggie Fick LONDON Some Britons are set to be able to get Wegovy weight-loss injections after Novo
2023-09-04 23:58
Strong U.S. demand eases pressure on Novo to show weight-loss drug's health benefits
By Maggie Fick LONDON Soaring U.S. demand for Novo Nordisk's weight-loss drug has reduced the pressure from investors
2023-07-14 13:15
Zealand, Boehringer's drug meets main weight-loss goal in mid-stage trial
By Ludwig Burger FRANKFURT Zealand Pharma and partner Boehringer Ingelheim said their experimental obesity drug achieved up to
2023-05-10 15:56